Mutation in malignant melanoma-: (A) N-myc, (B) CDK2A, (C) RET, (D) None
Answer is B. Ans. is 'b' i.e., CDK2A "In melanoma cells, numbers of mutations and/or dysregulated expression of B-Rof, N-Ras, CDK2A, MDM2, PTEN, p53 have been recognized". --Textbook of carcinogenesis